1.Heymann, D. Control of Communicable Diseases Manual. 18th ed. Washington DC: American Public Health Association; 2004:191–194.
2.Prusiner, SB. Shattuck lecture—neurodegenerative diseases and prions. N Engl J Med 2001; 344:1516–1526.
3.Fradkin, JE, Schonberger, LB, Mills, JL, et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 1991; 265:880–884.
4.Centers for Disease Control and Prevention. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts—Japan, January 1979-May 1996. MMWR Morb Mortal Wkly Rep 1997; 46:1066–1069.
5.Duffy, P, Wolf, J, Collins, G, DeVoe, AG, Streeten, B, Cowen, D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974; 290:692–693.
6.Tange, RA, Troost, D, Limburg, M. Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure. Eur Arch Otorhinolaryngol 1990; 247:199–201.
7.Bernoulli, C, Siegfried, J, Baumgartner, G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 1:478–479.
8.World Health Organization (WHO). WHO infection control guideline for transmissible spongiform encephalopathies: report of a WHO consultation. Geneva, Switzerland: WHO, 1999.
9.Scott, A, De, R, Sadek, SA, Garrido, MC, Courteney-Harris, RG. Temporal bone dissection: a possible route for prion transmission? J Laryngol Otol 2001; 115:374–375.